Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
167.00    2.00 (1.21%)
Bid:
165.50
Ask:
168.50
Spread: 3.00 (1.813%)
Market Cap: £32.61m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Further Share Buyback Programme

23 Apr 2026 07:00

RNS Number : 5561B
Palace Capital PLC
23 April 2026
 

LEI:2138009JDFQOXJFCJQ05

23 April 2026

Palace Capital PLC

 ("Palace Capital" or the "Company")

Further Share Buyback Programme

The Board of Directors (the "Board") of Palace Capital announces it has approved a share buyback programme of up to 300,000 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") (the "Buyback Programme") as a further step of a wider capital return programme it is progressing with its advisers.

The Company has instructed Cavendish to conduct the Buyback Programme on its behalf on a broker-managed basis, with trading decisions taken independently of the Company based parameters set by the Board. The Buyback Programme commences today and will end no later than six months from today, on 23 October 2026, or earlier if the maximum number of Ordinary Shares has been reached or the Company's buyback authority is not renewed at or before its next annual general meeting.

The Buyback Programme will be conducted in accordance with the terms of the Company's authority to make market purchases of its own Ordinary Shares granted to it by shareholders on 9 July 2025 (the "Authority"), including that the price paid per Ordinary Share will not be less than the nominal value of the Ordinary Shares, and the maximum price paid per Ordinary Share (excluding expenses) will be no more than the higher of either 105 per cent. of the average middle market closing price of an Ordinary Share as shown on the Daily Official List for the five business days preceding the date of any buyback; and an amount equal to the higher of the price of the last independent trade of an Ordinary Share and the highest current independent bid for an Ordinary Share on the trading venue where the purchase is carried out.

The Authority will expire on 9 October 2025 or, if earlier, at the conclusion of the Company's next annual general meeting ("AGM"), at which a proposal (amongst others) will be put to shareholders to renew the Company's ability to make market purchases of its Ordinary Shares. Accordingly, the Buyback Programme will continue after that date pursuant to such renewed authority and will be conditional on the approval of the same by shareholders. The Company intends to hold all Ordinary Shares so purchased in treasury during the course of the Buyback Programme and, following completion of the Buyback Programme, will seek to cancel the Ordinary Shares.

Due to the limited liquidity in the issued Ordinary Shares, a buyback of Ordinary Shares pursuant to the Authority (or its successor) on any given trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on the London Stock Exchange and could exceed 25 per cent. of the average daily trading volume and, accordingly, the Company will not benefit from the exemption contained in Article 5(1) of Regulation (EU) No. 596/2014 as adopted into UK law by the European Union (Withdrawal) Act 2018.

The Company will make further announcements in due course following any share purchases under the Buyback Programme.

 

Enquiries:

 

Palace Capital plcChristian Kappelhoff-Wulff, Non-Executive Chairmanckw@palacecapitalplc.com 

 

Financial PR

FTI ConsultingDido Laurimore / Andrew Davis

Tel: +44 (0)20 3727 1000

palacecapital@fticonsulting.com

 

Broker

Cavendish

Matt Lewis, Head of Corporate BrokingTel: +44 (0)20 7397 1920mlewis@cavendish.com

 

This announcement contains inside information for the purposes of Article 7 of the UK version of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKLAALLKEFA
Date   Source Headline
27th May 20264:57 pmRNSHolding(s) in Company
1st May 20261:45 pmRNSTotal Voting Rights
24th Apr 20269:15 amRNSHolding(s) in Company
24th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20267:00 amRNSFurther Share Buyback Programme
21st Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20263:03 pmRNSHolding(s) in Company
17th Apr 20267:00 amRNSShare Buyback Programme
16th Apr 20267:00 amRNSPORTFOLIO VALUATION AS AT 31 MARCH 2026
2nd Apr 20267:00 amRNSHolding(s) in Company
19th Mar 20267:00 amRNSDividend Declaration
4th Mar 20263:02 pmRNSHolding(s) in Company
9th Feb 20267:00 amRNSDisposal Update
23rd Jan 20264:30 pmRNSWithdrawal of Meeting Notice and Board Changes
8th Jan 20267:00 amRNSRESPONSE TO LAKESTREET CAPITAL’S ANNOUNCEMENT
5th Jan 202612:15 pmRNSResponse to Lakestreet Capital Partners AG
5th Jan 20267:00 amRNSLAKESTREET DEMANDS CHANGE AT PALACE CAPITAL
4th Dec 20259:01 amRNSHolding(s) in Company
4th Dec 20259:00 amRNSHolding(s) in Company
1st Dec 202512:47 pmRNSHolding(s) in Company
1st Dec 202512:45 pmRNSHolding(s) in Company
27th Nov 20251:32 pmRNSDividend Declaration
27th Nov 20257:00 amRNSInterim Results
5th Nov 202511:18 amRNSHolding(s) in Company
5th Nov 202511:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSHolding(s) in Company
25th Sep 20257:00 amRNSChange of Broker
18th Sep 20257:00 amRNSDividend Declaration
12th Sep 202512:02 pmRNSHolding(s) in Company
10th Sep 202512:07 pmRNSHolding(s) in Company
4th Sep 20251:59 pmRNSHolding(s) in Company
3rd Sep 202511:19 amRNSHolding(s) in Company
3rd Sep 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSResult of Tender Offer
26th Aug 202512:32 pmRNSResult of General Meeting
31st Jul 20257:00 amRNSProposed Tender Offer & Notice of General Meeting
9th Jul 202511:00 amRNSResult of AGM
6th Jun 202511:00 amRNSAnnual Report and Notice of Annual General Meeting
5th Jun 20257:00 amRNSPreliminary Results for year ended 31 March 2025
30th Apr 20257:00 amRNSTRADING AND STRATEGY UPDATE
17th Apr 20257:00 amRNSHolding(s) in Company
11th Apr 20251:30 pmRNSDISPOSALS, DEBT AND CASH UPDATE
11th Mar 20257:00 amRNSDividend Declaration
10th Dec 20241:12 pmRNSHolding(s) in Company
15th Nov 202412:59 pmRNSHolding(s) in Company
14th Nov 20247:00 amRNSInterim Results
12th Nov 202412:00 pmRNSNotice of Results
9th Oct 202412:16 pmRNSHolding(s) in Company
24th Sep 202412:00 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.